All filters
Meeting Report
Meeting Report Day 2 | J. Castillo-Mancilla | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | N. Thakkar | | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | V. Bukkems | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | M. Ferrara | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | S. Khoo | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | N. Sheehan | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | L. Walker | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | D. Hodge | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Long-Acting Drugs for Treatment and Prevention - Charles Flexner, MD (v)
Presented at:
Salvador HIV Clinical Forum 2021
Videos
2 vs 3 Drugs: When and for Whom? - Estevão Portela Nunes, MD, PhD (v)
Presented at:
Salvador HIV Clinical Forum 2021
Videos
Use of INSTIs in Women of Childbearing Age - Isabel Cassetti, MD (v)
Presented at:
Salvador HIV Clinical Forum 2021
Videos
Safety and Efficacy of INSTI in the Elderly - Anton Pozniak, MD, FRCP (v)
Presented at:
Salvador HIV Clinical Forum 2021
Videos
Use of INSTI in Patients With Comorbidities and Polypharmacy - Marta Boffito, MD, PhD, FRCP (v)
Presented at:
Salvador HIV Clinical Forum 2021
Abstracts
Key Considerations for the Introduction of Hepatitis B Birth Dose Vaccine in Cameroon
D. Kamga
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
A Community of Practice for the Introduction and Scale-up of Hepatitis B Birth Dose Vaccination in Africa: Challenges, Opportunities, and Lessons Learned
H. Njuguna
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Hépatite Delta au Senegal
M. Balkissa
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Long Term Follow up of Chronic Hepatitis B Cohort in Africa; The Prolifica Gambia Exprience
I. Mahmoud
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Assessment of Fibrosis Markers in HEPSANET: A Collaborative Network of Hepatitis B Cohorts in Sub-Saharan Africa
A. Johannessen
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Age Cohort Screening for Hepatocellular Carcinoma in an African Population
J. Makpu
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021